Krystsina Babkova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Krystsina Babkova has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Alicja Korpacka
Our Lady of Perpetual Help Hospital, Wołomin, Poland
5 shared publications - Iuliia Ilina
Our Lady of Perpetual Help Hospital, Wołomin, Poland
5 shared publications - Maryia Bohdzel
Medical University of Warsaw, Warsaw, Poland
5 shared publications - Nadzeya Skadorva
Jan-Mikulicz Radziecki University Clinical Hospital in Wrocław, Wrocław, Poland
5 shared publications - Patrycja Anna Borowiecka
Our Lady of Perpetual Help Hospital, ul. Gdyńska 1/3, 05-200 Wołomin, Poland
5 shared publications - Pavel Proborshch
Our Lady of Perpetual Help Hospital, Wołomin, Poland
5 shared publications
Latest Publications
- Open Access
- 28 September 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 5 (3(51))
OBESITY IN CHILDREN AND ADOLESCENTS – HEALTH EFFECTS, METHODS OF PREVENTION AND TREATMENT
Introduction: Obesity is becoming an increasingly common and serious condition in children and adolescents. It is diagnosed when the body mass index (BMI) exceeds the 97th percentile for age and sex in children and adolescents. This condition causes serious health problems and increases the risk of chronic diseases.. Discussion: With the rise in obesity among the paediatric population, there has also been an increase in cardiovascular, pulmonary and endocrinological problems, amongst many others. Various approaches are used to treat obesity in children and adolescents. One such approach is pharmacological treatment using the medication Orlistat. Other methods include diet, regular physical activity and psychotherapy. The National Nutrition and Health Programme is an example of a scheme that sets out the basic principles of a balanced diet. In children with obesity, metformin is recommended to prevent diabetes mellitus. Bariatric surgery is another treatment option. The best results were observed when lifestyle changes were combined with Orlistat. An individualised approach to treating obesity in children and adolescents is recommended. Even though new health programmes and campaigns are implemented, parents should pay attention to their children’s physical and mental health. Conclusions: Obesity entails many consequences such as chronic diseases, reduced quality of life and psychosocial problems. A better understanding of obesity mechanisms will help develop more effective ways to tackle it.. There is a need for research that will provide information on society’s knowledge in this area and on the most effective channels for promoting awareness of a healthy lifestyle.
- 28 September 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 5 (3(51))
Open AccessOBESITY IN CHILDREN AND ADOLESCENTS – HEALTH EFFECTS, METHODS OF PREVENTION AND TREATMENT
Introduction: Obesity is becoming an increasingly common and serious condition in children and adolescents. It is diagnosed when the body mass index (BMI) exceeds the 97th percentile for age and sex in children and adolescents. This condition causes serious health problems and increases the risk of chronic diseases.. Discussion: With the rise in obesity among the paediatric population, there has also been an increase in cardiovascular, pulmonary and endocrinological problems, amongst many others. Various approaches are used to treat obesity in children and adolescents. One such approach is pharmacological treatment using the medication Orlistat. Other methods include diet, regular physical activity and psychotherapy. The National Nutrition and Health Programme is an example of a scheme that sets out the basic principles of a balanced diet. In children with obesity, metformin is recommended to prevent diabetes mellitus. Bariatric surgery is another treatment option. The best results were observed when lifestyle changes were combined with Orlistat. An individualised approach to treating obesity in children and adolescents is recommended. Even though new health programmes and campaigns are implemented, parents should pay attention to their children’s physical and mental health. Conclusions: Obesity entails many consequences such as chronic diseases, reduced quality of life and psychosocial problems. A better understanding of obesity mechanisms will help develop more effective ways to tackle it.. There is a need for research that will provide information on society’s knowledge in this area and on the most effective channels for promoting awareness of a healthy lifestyle.
- Open Access
- 30 June 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 5 (2(50))
THE ROLE OF ARTIFICIAL INTELLIGENCE IN THE DIAGNOSIS OF RETINAL DISEASES
Background: Retinal diseases such as diabetic retinopathy, age-related macular degeneration, and glaucoma are major causes of vision loss and blindness around the world. Detecting these conditions early and treating them promptly is key to preventing them from worsening and saving sight. New developments in artificial intelligence (AI), especially in machine learning (ML) and deep learning (DL), now offer better ways to automatically analyze retinal images and help doctors make more accurate diagnoses in eye care. Methods: A narrative literature review was carried out using the PubMed database to find peer-reviewed studies on artificial intelligence in diagnosing retinal diseases. The review included recent studies that assessed AI algorithms used with retinal imaging methods like fundus photography and optical coherence tomography (OCT). Results: Multiple studies indicate that AI algorithms can accurately detect retinal diseases. Deep learning models, particularly convolutional neural networks, are effective at identifying features linked to diabetic retinopathy, age-related macular degeneration and glaucoma. Some AI systems for diabetic retinopathy screening have achieved sensitivities and specificities above 90%, which is comparable to experienced ophthalmologists. Furthermore, AI-based analysis of OCT images has shown promise in detecting structural retinal changes and monitoring disease progression. Conclusions: Artificial intelligence could greatly improve how retinal diseases are diagnosed and screened by allowing fast and accurate analysis of retinal images. Although there are still challenges with data quality, transparency, and clinical use, AI-based diagnostic systems will likely become an important part of future eye care.
- 30 June 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 5 (2(50))
Open AccessTHE ROLE OF ARTIFICIAL INTELLIGENCE IN THE DIAGNOSIS OF RETINAL DISEASES
Background: Retinal diseases such as diabetic retinopathy, age-related macular degeneration, and glaucoma are major causes of vision loss and blindness around the world. Detecting these conditions early and treating them promptly is key to preventing them from worsening and saving sight. New developments in artificial intelligence (AI), especially in machine learning (ML) and deep learning (DL), now offer better ways to automatically analyze retinal images and help doctors make more accurate diagnoses in eye care. Methods: A narrative literature review was carried out using the PubMed database to find peer-reviewed studies on artificial intelligence in diagnosing retinal diseases. The review included recent studies that assessed AI algorithms used with retinal imaging methods like fundus photography and optical coherence tomography (OCT). Results: Multiple studies indicate that AI algorithms can accurately detect retinal diseases. Deep learning models, particularly convolutional neural networks, are effective at identifying features linked to diabetic retinopathy, age-related macular degeneration and glaucoma. Some AI systems for diabetic retinopathy screening have achieved sensitivities and specificities above 90%, which is comparable to experienced ophthalmologists. Furthermore, AI-based analysis of OCT images has shown promise in detecting structural retinal changes and monitoring disease progression. Conclusions: Artificial intelligence could greatly improve how retinal diseases are diagnosed and screened by allowing fast and accurate analysis of retinal images. Although there are still challenges with data quality, transparency, and clinical use, AI-based diagnostic systems will likely become an important part of future eye care.
- Open Access
- 25 June 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 4 (2(50))
PHYSICAL ACTIVITY AS A PRIMARY PREVENTION STRATEGY FOR ALZHEIMER'S DISEASE: A COMPREHENSIVE REVIEW OF NEUROBIOLOGICAL MECHANISMS AND CLINICAL EVIDENCE
Alzheimer's disease (AD) represents an important public health crisis, as current treatment interventions have shown limited effects in altering disease progression after the onset of clinical symptoms. Neurodegeneration begins approximately 2 decades before clinical manifestation, providing a considerable window for preventive measures. This detailed review synthesises evidence from longitudinal epidemiological studies, randomised controlled trials and preclinical models to explain the neurobiological mechanisms underlying exercise-induced neuroprotection. Analysis of data from over 200,000 participants across multiple cohorts shows that structured physical activity reduces AD risk by 38-51%, with dose-dependent relationships found across intensity levels. Mechanistically, exercise targets multiple pathways involved in AD pathogenesis, including enhancing amyloid-β clearance via activation of the glymphatic system, upregulating neurotrophic cascades such as BDNF/TrkB signalling, improving cerebrovascular function through endothelial nitric oxide synthase activation, and regulating neuroinflammatory responses through microglial phenotype switching. Significant gaps remain in the current literature. Most evidence is derived from observational studies involving cognitively normal populations and there is limited data regarding optimal exercise prescriptions for individuals with preclinical AD pathology. Additionally, sex-specific responses and genetic modifiers, such as APOE ε4 status, require more investigation to inform personalised prevention strategies. The evidence indicates the need for a fundamental change in clinical practice: physical activity should be prescribed in the same way as pharmacological interventions, with careful choice of timing, intensity, and duration. Exercise should be recognised as a medical intervention, not simply a lifestyle recommendation, especially for the ageing population. To convert evidence into practice, an organised approach to exercise prescription is recommended. This includes assessing physical activity levels and individual risk factors, developing a detailed exercise plan specifying frequency, intensity, type and duration, and providing guidance on safe progression. Scheduled follow-up visits are important for monitoring the outcomes, adjusting prescriptions as needed and removing barriers. This stepwise approach supports the integration of exercise into routine clinical care, ensuring that preventive methods for cognitive health are both evidence-based and actionable.
- 25 June 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 4 (2(50))
Open AccessPHYSICAL ACTIVITY AS A PRIMARY PREVENTION STRATEGY FOR ALZHEIMER'S DISEASE: A COMPREHENSIVE REVIEW OF NEUROBIOLOGICAL MECHANISMS AND CLINICAL EVIDENCE
Alzheimer's disease (AD) represents an important public health crisis, as current treatment interventions have shown limited effects in altering disease progression after the onset of clinical symptoms. Neurodegeneration begins approximately 2 decades before clinical manifestation, providing a considerable window for preventive measures. This detailed review synthesises evidence from longitudinal epidemiological studies, randomised controlled trials and preclinical models to explain the neurobiological mechanisms underlying exercise-induced neuroprotection. Analysis of data from over 200,000 participants across multiple cohorts shows that structured physical activity reduces AD risk by 38-51%, with dose-dependent relationships found across intensity levels. Mechanistically, exercise targets multiple pathways involved in AD pathogenesis, including enhancing amyloid-β clearance via activation of the glymphatic system, upregulating neurotrophic cascades such as BDNF/TrkB signalling, improving cerebrovascular function through endothelial nitric oxide synthase activation, and regulating neuroinflammatory responses through microglial phenotype switching. Significant gaps remain in the current literature. Most evidence is derived from observational studies involving cognitively normal populations and there is limited data regarding optimal exercise prescriptions for individuals with preclinical AD pathology. Additionally, sex-specific responses and genetic modifiers, such as APOE ε4 status, require more investigation to inform personalised prevention strategies. The evidence indicates the need for a fundamental change in clinical practice: physical activity should be prescribed in the same way as pharmacological interventions, with careful choice of timing, intensity, and duration. Exercise should be recognised as a medical intervention, not simply a lifestyle recommendation, especially for the ageing population. To convert evidence into practice, an organised approach to exercise prescription is recommended. This includes assessing physical activity levels and individual risk factors, developing a detailed exercise plan specifying frequency, intensity, type and duration, and providing guidance on safe progression. Scheduled follow-up visits are important for monitoring the outcomes, adjusting prescriptions as needed and removing barriers. This stepwise approach supports the integration of exercise into routine clinical care, ensuring that preventive methods for cognitive health are both evidence-based and actionable.
- Open Access
- 23 June 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 4 (2(50))
IMPACT OF INSULIN RESISTANCE ON REPRODUCTIVE OUTCOMES IN WOMEN WITH PCOS
Insulin resistance (IR) is a key metabolic abnormality in polycystic ovary syndrome (PCOS) and is strongly linked to reproductive dysfunction. However, the specific impact of insulin resistance on reproductive outcomes remains unclear. This review explores the current evidence on the impact of insulin resistance on reproductive results in women with PCOS. A systematic search of PubMed/MEDLINE and Google Scholar was performed to identify relevant studies published through March 2025. Research consistently demonstrates a correlation between insulin resistance, anovulation, ovulatory problems, and an increased risk of miscarriage. This could also raise the likelihood of developing gestational diabetes and may adversely impact results in assisted reproductive technology (ART). Although obesity is often seen as a contributing factor, many studies indicate that insulin resistance alone can considerably impact reproductive outcomes. Elevated insulin levels can increase ovarian androgen production, decrease sex hormone-binding globulin (SHBG), and disrupt normal follicular development. Interventions that enhance insulin sensitivity, including lifestyle modifications and, when appropriate, metformin treatment, can improve metabolic health and potentially lead to better reproductive outcomes. Insulin resistance plays a significant role in causing reproductive dysfunction in women with PCOS, highlighting how important it is to evaluate and manage metabolic health as a vital part of fertility treatment.
- 23 June 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 4 (2(50))
Open AccessIMPACT OF INSULIN RESISTANCE ON REPRODUCTIVE OUTCOMES IN WOMEN WITH PCOS
Insulin resistance (IR) is a key metabolic abnormality in polycystic ovary syndrome (PCOS) and is strongly linked to reproductive dysfunction. However, the specific impact of insulin resistance on reproductive outcomes remains unclear. This review explores the current evidence on the impact of insulin resistance on reproductive results in women with PCOS. A systematic search of PubMed/MEDLINE and Google Scholar was performed to identify relevant studies published through March 2025. Research consistently demonstrates a correlation between insulin resistance, anovulation, ovulatory problems, and an increased risk of miscarriage. This could also raise the likelihood of developing gestational diabetes and may adversely impact results in assisted reproductive technology (ART). Although obesity is often seen as a contributing factor, many studies indicate that insulin resistance alone can considerably impact reproductive outcomes. Elevated insulin levels can increase ovarian androgen production, decrease sex hormone-binding globulin (SHBG), and disrupt normal follicular development. Interventions that enhance insulin sensitivity, including lifestyle modifications and, when appropriate, metformin treatment, can improve metabolic health and potentially lead to better reproductive outcomes. Insulin resistance plays a significant role in causing reproductive dysfunction in women with PCOS, highlighting how important it is to evaluate and manage metabolic health as a vital part of fertility treatment.
- Open Access
- 21 April 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 54, 70647
Antiviral peptides as emerging therapeutic agents: a narrative review of engineering strategies, delivery innovations, and clinical perspectives
Background. Viral infections remain a major global health threat despite advances in vaccines and antiviral drugs due to the rapid emergence of resistance and new viral pathogens. Antiviral peptides (AVPs) are promising broad-spectrum therapeutic agents because of their structural diversity and multiple biological activities. Aim. The aim of this narrative review is to summarize current knowledge on antiviral peptides, focusing on their classification, mechanisms of action, molecular engineering strategies, delivery systems, and clinical perspectives. Material and methods. A narrative review of recent peer-reviewed literature on antiviral peptides, engineering techniques, and modern drug-delivery approaches, including liposomes, polymer nanoparticles, and mucosal systems, was conducted. Results. AVPs act at multiple stages of viral replication, including inhibition of viral attachment and fusion, disruption of viral envelopes, interference with intracellular replication, and modulation of immune responses. Engineering strategies such as cyclization, PEGylation, D-amino acids, and lipidation improve stability and pharmacokinetics, while novel delivery systems enhance bioavailability. Clinical translation is limited by short half-life, toxicity, cost, and regulatory challenges. Conclusions. Antiviral peptides are promising broad-spectrum therapeutics, and further interdisciplinary research is needed to enable their clinical application.
- 21 April 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 54, 70647
Open AccessAntiviral peptides as emerging therapeutic agents: a narrative review of engineering strategies, delivery innovations, and clinical perspectives
Background. Viral infections remain a major global health threat despite advances in vaccines and antiviral drugs due to the rapid emergence of resistance and new viral pathogens. Antiviral peptides (AVPs) are promising broad-spectrum therapeutic agents because of their structural diversity and multiple biological activities. Aim. The aim of this narrative review is to summarize current knowledge on antiviral peptides, focusing on their classification, mechanisms of action, molecular engineering strategies, delivery systems, and clinical perspectives. Material and methods. A narrative review of recent peer-reviewed literature on antiviral peptides, engineering techniques, and modern drug-delivery approaches, including liposomes, polymer nanoparticles, and mucosal systems, was conducted. Results. AVPs act at multiple stages of viral replication, including inhibition of viral attachment and fusion, disruption of viral envelopes, interference with intracellular replication, and modulation of immune responses. Engineering strategies such as cyclization, PEGylation, D-amino acids, and lipidation improve stability and pharmacokinetics, while novel delivery systems enhance bioavailability. Clinical translation is limited by short half-life, toxicity, cost, and regulatory challenges. Conclusions. Antiviral peptides are promising broad-spectrum therapeutics, and further interdisciplinary research is needed to enable their clinical application.